Objective: To compare two low fat diets one rich in walnuts on parameters of lipid metabolism in a group of hyperlipidaemic subjects. Design: A randomised cross over study. Setting: Department of Human Nutrition, University of Otago, Dunedin, New Zealand Subjects: Twenty one men with mean (s.d) levels of total and LDL cholesterol of 6.58 (0.60) and 4.63 (0.58) respectively. Interventions: For two periods of four weeks subjects were asked to consume two low fat diets (fat 30% total energy), one containing, on average, 78 gad walnuts. Walnuts obtained through Lincoln University and the Walnut Growers Group (South Canterbury). Results: Participants reported a higher total fat intake on the walnut diet (38% compared with 30% on the low fat diet P`0.01) The most consistent change in fatty acid pro®le of triacylglycerol, phospholipid and cholesterol ester on the walnut diet was a signi®cant (P`0.01) increase in linoleic acid. Triacylglycerol linolenate also increased signi®cantly (P`0.01). Total and LDL cholesterol were lower on both experimental diets than at baseline, 0.25 mmolal and 0.36 mmolal respectively on the walnut diet and 0.13 mmolal and 0.20 mmolal respectively on the low fat diet. High density lipoprotein cholesterol was higher on both the walnut and low fat diets when compared to baseline (0.15 mmolal and 0.12 mmolal, respectively). When comparing the walnut and low fat diets only apo B was signi®cantly lower (P`0.05) on the walnut diet. Conclusions: Despite an unintended increase in the total fat intake on the walnut diet, fatty acid pro®le of the major lipid fractions showed changes which might be expected to reduce risk of cardiovascular disease. The reduction of apolipoprotein B suggests a reduction in lipoprotein mediated risk, the relatively low myristic acid content of both diets perhaps explaining the absence of more extensive differences in lipoprotein levels on the two diets.
Introduction
Diets low in total and saturated fat have long been recommended for reduction of total and low density lipoprotein cholesterol and to reduce coronary heart disease (CHD) risk (National Cholesterol Education Programme, 1991, Recommendations of the European Atherosclerosis Society, 1992). More recently it has become apparent that certain long chain unsaturated fatty acids may protect against CHD and that this protective effect may be as strong as the deleterious effect of a high saturated fat diet. Several epidemiological studies have shown reduced rates of heart disease among vegetarians (Burr & Butland, 1988; Thorogood et al, 1994) but there is no clear evidence that elimination of meat, ®sh, and food products derived from them, accounts for this bene®cial effect. Indeed, prospective studies of Seventh Day Adventists suggest that regular consumption of nuts and wholemeal bread may be important protective factors (Fraser et al, 1992) . Two research groups Abbey et al, 1994) have examined the effects of various nuts on lipids and lipoproteins in normolipidaemic male volunteers in an attempt to clarify the mechanism by which nuts might exert their protective effect. We have persued this issue further by examining the effects of walnuts on lipids, lipoproteins and triacylglycerol fatty acids in men with moderately raised cholesterol levels.
Methods

Subjects
Twenty one men were recruited following advertisement in the local news media in Dunedin, New Zealand or from among participants in previous studies conducted in the Department of Human Nutrition, University of Otago. Subjects were required to be below 65 y of age and to have levels of total cholesterol between 5.5±7.5 mmolal. At the time of recruitment all were free of symptoms of disease and none had a strong family history of premature coronary heart disease. Those with familial hypercholesterolaemia, familial combined hyperlipidaemia or secondary hyperlipidaemia were also excluded. Thus all were considered to have polygenic hyperlipidaemia. Ethical approval for the study was granted by the Ethics Committee (Otago) of the Southern Regional Health Authority and all subjects gave informed consent on the understanding that they could withdraw from the study at any time. The subjects initial mean (s.d.) age was 45 (6.8) 
Experimental design
A randomised cross over design was employed. All participants consumed both the walnut and reference diets. The study involved a run in period of one week during which a standard lipid lowering diet was advised. The purpose of the run in period was to allow participants time to practise the dietary modi®cations, to achieve a diet in which total fat provided 30% total energy, but of short enough duration not to cause a marked change in lipid levels. Thereafter participants were randomised into two groups, Group 1 continued on the`Low Fat Diet' ®rst and Group 2 thè Walnut Diet'. After four weeks on the ®rst diet the participants crossed over to the alternate diet. Blood samples were taken after an overnight fast once at the end of the run in period (baseline) and twice during the ®nal week of each phase of the study. The values for the various parameters measured on each diet are the mean of the measurements made on the two occasions. After the initial four day diet record during the run in period, eight day diet records were collected during each experimental period by recording food eaten on two different days each week.
Diets
As participants in this study ate all meals at home and followed their usual activities, detailed dietary counselling was provided to individuals, and where appropriate their partners. The experimental diets were individually prescribed and based on estimated energy requirement and reported intake during the baseline. Diets were calculated (in increments of 100 kcala419 kJ, to cover the range from 1800 kcala7533 kJ to 3000 kcala12556 kJ) on the basis of information obtained from the four day diet record. Walnuts contributed 20% of the total energy and 55% of energy from fat in the walnut diet with the remaining fat coming from foods chosen by the participants according to preference and their daily eating patterns. During the Low Fat Diet all fat came from a variety of foods other than nuts. The dietary methodology used a food exchange system, developed in this department (Chisholm et al, 1992) , in order to facilitate the achievement of fat targets appropriate to a particular experimental diet. The system permitted the subjects to utilize a wide range of fat containing foods from meat or poultry, dairy, ®sh, made up dishes or baked product sources in order to achieve their fat from food targets. A selection of recipes, with a fat per serving analysis, were supplied together with sample menu plans for both the walnut and low fat diet phases. Some of the recipes were for use in both phases of the study while others incorporating walnuts were designed speci®cally for this intervention. It was assumed that these recipes would be utilized not only by the study subjects but also for their families, so information on how to adjust the fat per serving according to the number of servings a recipe may yield was also supplied. For example a 2500 kcal low fat diet permitted 83 gm fat from food. The walnut diet at the same energy levels was calculated to contain 46 gm fat from walnuts and 37 gm fat from food. Participants received an individual instruction folder containing details of the methodology and its practical application, including recipes. Nutrient intake was calculated using the computer program`Diet Entry and StorageaDiet Cruncher' (Marshall,1993) and data from the New Zealand Food Composition database (Burlingam et al, 1993) . New Zealand walnuts obtained through Lincoln University and the Walnut Growers Group (South Canterbury) were supplied, already shelled and weighed out to the participants. The fatty acid composition of the walnuts used in this study is shown in Table 1 .
Laboratory methods
Cholesterol concentrations in plasma and lipoprotein fractions were measured by enzymatic methods using kits and calibrators from Boehringer Mannheim, and triacylglycerol were measured enzymatically with Roche Diagnostic kits on a Cobas Fara analyser (Roche Diagnostics). Calibration and quality control was maintained by participation in the Royal Australasian College of Pathologists Quality Assurance Programme. Coef®cient of variation for measurement of cholesterol was 1.6% and for triacylglycerol 3.4%. High density lipoprotein cholesterol was measured in the supernatant after precipitation of apo BÐcontaining lipoproteins with phosphotungstateamagnesium chloride (Assmann et al, 1983) . LDL-C was calculated using the Friedewald formula (Friedewald et al, 1972) . Apolipoprotein AI and apolipoprotein B concentrations were determined by immunoturbidimetry using commercial kits from Boehringer (Coef®cient of variation 2.6 and 6.0% respectively). Plasma lipids were extracted according to the procedure of Bligh & Dyer (1959) and the various lipid fractions separated by thin layer chromatography. Fatty acid composition of each fraction was analysed by gas liquid chromatography (Holub & Skeaff, 1987) . The precision of the fatty acid measurement was determined by repeated analysis of a pooled plasma sample. The coef®cient of variation for all fatty acids present at greater than 1 mol % in the pooled sample ranged from 1±4%.
Statistics
For all variables, the two measurements made during the last week of each period were not signi®cantly different from one another so the means of the two values were used. Preliminary analyses of the data included a repeated measures ANOVA to determine whether the order of the interventions in¯uenced the relative treatment response. The means shown to compare the two diets are pooled over the two sequences. Differences between the two diets were compared using ANOVA with repeated measures.
Results
All 21 subjects attended all appointments but only 16 provided a full set of dietary records. Data are presented for these subjects. Body weight on the two experimental Table 2 . On both experimental diets total and LDL cholesterol and apo B were lower than at baseline, but the differences were signi®cant only for the walnut diet. Apo B was signi®cantly lower at the end of the walnut diet in comparison to the low fat diet (P`0.05). Total and LDL cholesterol were slightly lower at the end of the walnut diet in comparison to the low fat diet but these differences were not statistically signi®cant. The HDL values were similar on both experimental diets and signi®cantly higher than at baseline (P`0.01). Those who received the walnut diet ®rst (group 2) showed a reduction in both TC and LDL-C from baseline to the end of the walnut diet (70.17 and 70.27 mmolal, respectively) followed by a reduction from the end of the walnut diet to the end of the low fat diet of 70.27 and 70.24 mmolal respectively. Group 1 receiving the low fat diet ®rst showed a slight rise in TC and LDL-C values from baseline ( 0.16 and 0.10 mmolal respectively) to the end of this diet phase but then a marked drop from the end of the low fat diet of 70.50 and 70.63 mmolal to the end of the walnut diet. Fatty acids were measured in plasma triacylglycerol, cholesterol esters and phospholipids. The analysis of the plasma triacylglycerol fatty acid values showed signi®cant changes in the levels of C16:1, C18:1, C18:2n-6 and C18:3n-3; the plasma cholesterol ester in levels of C16:0, C18:1, and C18:2n-6; and the plasma phospholipid in levels of C16:1, C18:0, C18:1, and C18:2n-6, between the walnut and low fat diets. (Tables 3, 4 and 5). The mean nutrient intake values on the two diets are shown in Table 6 . Intakes of total, saturated and polyunsaturated fatty acids, carbohydrate and protein (expressed as a percentage of total energy) were signi®cantly different on the two diets. The low fat diet was higher in saturated fat and dietary cholesterol, the walnut diet higher in total and polyunsaturated fat. Carbohydrate and protein intakes were higher on the low fat diet. The mean daily intake of walnuts was 78 g per day on the walnut diet. This supplied 53 g of fat, 30 g of which came from linoleic acid and 5.9 g from linolenic acid.
Discussion
Our aim in this study was to compare two diets of similar energy content both meeting current recommendations for macronutrient intakes (National Cholesterol Education Pro- . Unless otherwise reported, fatty acids contributing less than 0.5 mol% are omitted. *P`0.05; **P`0.01. . Unless otherwise reported, fatty acids contributing less than 0.5 mol% are omitted. *P`0.05; **P`0.01 gramme, 1994). In the walnut diet the intention was for participants to replace various other fat sources with the nuts provided. Compliance with the consumption of walnuts was very good, as evidenced by the large relative increases of linoleic acid in plasma triacylglycerol, by 6.0 mol% and alpha linolenic acid, by 0.8 mol%. The marked decrease in oleic acid content of plasma triacylglycerol is another characteristic marker of increased linoleic acid intake (Abbey et al, 1994; Kelley et al, 1993; Vasta et al, 1996) and further con®rmation that compliance with the walnut regimen was high. Regrettably, despite detailed dietary instructions and regular reinforcement throughout the experimental period total energy from fat was higher on the walnut diet. The data given in Table 6 and examination of the food records suggest that instead of replacing other high fat foods with walnuts the participants were consuming the raw nuts in addition to their usual food. Nevertheless, the diets were essentially isocaloric and some food substitution was evident. On the low fat diet in comparison to the walnut diet mean amounts consumed were increased for meat, (164 vs 102 gad), dairy products (228 vs 217 gad), bakery products (179 vs 164 gad), and fruit (167 vs 132 gad). With hindsight it would have been preferable to have adopted an approach which did not rely on the fat exchange concept. However, our success with this approach in previous studies (Chisholm et al, 1992; Cox et al, 1995) , encouraged its continued use and we believe that despite a higher fat intake in the walnut group interesting ®ndings have nevertheless emerged. The most relevant ®ndings concern the plasma fatty acids. These ®ndings are broadly comparable with those of Sabate et al (1993) and Abbey et al (1994) who studied healthy young men at low risk of coronary heart disease (CHD). The most striking change on the walnut diet was the increase in linoleic acid in all plasma fatty acid fractions and the increase in alpha linolenic acid in plasma triacylglycerol. There is reasonably convincing evidence that linoleic acid may be protective against CHD (Riemersma et al, 1986; Hetzel et al, 1989; Roberts et al, 1993) and there is emerging evidence of the importance of dietary alpha linolenic acid.
The cardioprotective effects of linolenic acid have recently been highlighted by results from the Health Professionals study. Aschiro et al, (1996) found that a one percent increase in total energy from linolenic acid was associated with a relative risk of myocardial infarction of 0.4 after adjustment for total fat intake, this ®nding was the most striking dietary factor associated with reduced risk (Aschiro et al, 1996) . In a secondary prevention trial de Lorgeril et al, 1994 randomised post myocardial infarction patients to a conventional`prudent' diet or a`Mediterranean' diet rich in alpha linolenic acid. There was an approximately two thirds reduction in non fatal myocardial infarction and cardiac death in the latter group. Although con®dence intervals were relatively wide and it is dif®cult to be certain that the results were entirely due to the effects of alpha linolenate rather than the other characteristics of the Mediterranean diet, the data certainly support the suggestion that this fatty acid has the potential to reduce cardiovascular risk (de Lorgeril et al, 1994) . Alpha linolenic acid may be protective directly, in which case, the increased alpha linolenic content of plasma triacylglycerol during the walnut diet would be bene®cial. Alternately, the desaturation and elongation of alpha linolenic to eicosapentaenoic acid, leading to increased tissue levels of eicosapentaenoic acid may be protective (Schmidt & Dyerberg, 1994) . In this regard the walnut diet did not produce increased eicosapentaenoic acid levels in plasma triacylglycerol, phospholipid or cholesterol ester. This ®nding is consistent with that of Abbey et al (1994) who found that walnuts did not increase plasma eicosapentaenoic acid when compared to a reference diet with a PaS ratio of 0.4-similar to our low fat diet-but is in contrast to that of Sabate et al (1993) . The n-6an-3 polyunsaturated fatty acid ratio in walnuts is roughly 5:1 (Quigley et al, 1995) , whereas in canola and¯axseed oils, also advocated for their alpha linolenic acid content, the ratios are roughly 2:1 (Quigley et al, 1995) and 1:4 (Layne et al, 1996) , respectively. Chan et al (1993) and others (Abbey et al, 1994; Layne et al, 1996; Lichtenstein et al, 1993 , Valsta et al, 1996 have reported that when using alpha linolenic acid rich oils if the n-6an-3 ratio in the overall diet is high (namely b 5) an increase in plasma alpha linolenic acid can occur, but there is little, if any, increase in eicosapentaenoic acid content of plasma lipids above that of a standard reference diet. Increasing eicosapentaenoic acid levels by consuming alpha linolenic acid-rich oils appears to require a low n-6an-3 ratio (namely`3) in the overall diet as well as a high intake of alpha linolenic acid (Chan et al, 1993; Mantzioris et al, 1994 Mantzioris et al, , 1995 , not easily achieved by supplementing a low fat diet with walnuts, as in the present experiment.
The ®ndings relating to lipids and lipoproteins are more dif®cult to interpret. It should be noted that on both experimental diets total and LDL cholesterol and apolipoprotein B were lower than at baseline, however this was only signi®cant for the walnut diet. The only statistically signi®cant difference between the walnut and low fat diets was a lower level of apo B though there was also a trend towards lower LDL and a higher HDL on the walnut diet. An explanation may be found in the lack of difference, between the two treatment groups in the myristic acid composition of plasma triacylglycerol. In a previous study (Cox et al, 1995) , in which the effects of butter, coconut oil, and saf¯ower oil on plasma lipids were compared, we reported that a saf¯ower oil diet reduced plasma total cholesterol by 10% in comparison to a butter diet. Myristic acid content of plasma triacylglycerol on the butter diet was 4.4 mol%, whereas on the saf¯ower oil diet it was 2.6 mol% (P`0.01). In the present study, the myristic acid content of plasma triacylglycerol on the walnut and low fat diets were 2.8 and 3.0 mol%, respec- 38 (4) 30 (4)** SFA (% total energy) 10 (2) 12 (3)** MUFA (% total energy) 10 (2) 10 (2) PUFA (% total energy) 16 (3) 5 (1)** Alcohol (% total energy) 4 (4) 5 (4) tively. Myristic acid has the strongest cholesterol raising properties of the saturated fatty acids (Katan et al, 1994) and it is tempting to speculate that the equally low level of myristic acid in plasma triacylglycerol of the walnut and low fat groups explains why, despite an increase in linoleic acid content of plasma triacylglycerol (by 6.0 mol%) similar to that found between the butter and saf¯ower oil diets (by 6.8 mol%) in our earlier study, the walnut diet did not reduce plasma cholesterol concentrations.
Conclusions
Thus our data con®rm the potential for walnuts to in¯uence the fatty acid pro®le of plasma lipids in a way which might be expected to reduce the risk of coronary heart disease. This may explain the cardioprotective effect of nuts observed in studies of vegetarians. Other studies have suggested an improvement in the overall lipoprotein pro®le in those consuming substantial quantities of walnuts. Failure to show more convincing differences between the walnut and low fat diets in this study may have been due to the relatively similar intakes of myristic acid on both diets. Clearly any advice to increase nut consumption which might follow further con®rmation of these ®ndings should indicate a note of caution to avoid an increase in total fat intake.
